BrainsWay Ltd. (ADR)
General ticker "BWAY" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $227.9M (TTM average)
BrainsWay Ltd. (ADR) follows the US Stock Market performance with the rate: 62.5%.
Estimated limits based on current volatility of 3.0%: low 14.33$, high 15.21$
Factors to consider:
- Total employees count: 107 as of 2019
- Current price 25.9% above estimated high
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [7.17$, 12.50$]
- 2026-12-31 to 2027-12-31 estimated range: [7.48$, 13.06$]
Financial Metrics affecting the BWAY estimates:
- Positive: with PPE of 29.3 at the end of fiscal year the price was very low
- Positive: 6.62 < Operating cash flow per share per price, % of 10.36
- Positive: Interest expense per share per price, % of 1.27 <= 3.34
- Positive: 7.57 < Operating profit margin, % of 8.28
- Positive: Industry inventory ratio change (median), % of 0.25 <= 0.28
- Negative: negative Industry operating income (median)
- Positive: Return on assets ratio (scaled to [-100,100]) of 6.33 > 6.02
Short-term BWAY quotes
Long-term BWAY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $31.79MM | $41.02MM | $52.23MM |
| Operating Expenses | $36.74MM | $39.62MM | $47.90MM |
| Operating Income | $-4.96MM | $1.39MM | $4.32MM |
| Non-Operating Income | $1.01MM | $2.07MM | $3.39MM |
| Interest Expense | $0.30MM | $1.36MM | $2.23MM |
| R&D Expense | $6.67MM | $7.19MM | $9.60MM |
| Income(Loss) | $-3.95MM | $3.46MM | $7.71MM |
| Taxes | $0.25MM | $0.54MM | $0.08MM |
| Net Income(Loss)* | $-4.20MM | $2.92MM | $7.63MM |
| Stockholders Equity | $41.58MM | $62.31MM | $73.22MM |
| Inventory | $3.72MM | $4.43MM | $7.13MM |
| Assets | $62.97MM | $94.32MM | $112.92MM |
| Operating Cash Flow | $1.28MM | $10.30MM | $18.16MM |
| Capital expenditure | $2.39MM | $3.79MM | $1.76MM |
| Investing Cash Flow | $-37.41MM | $30.31MM | $-17.63MM |
| Financing Cash Flow | $-1.03MM | $18.26MM | $-2.23MM |
| Earnings Per Share** | $-0.13 | $0.09 | $0.40 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.